These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 16713394)
1. Trans fatty acids and blood lipids. Ascherio A Atheroscler Suppl; 2006 May; 7(2):25-7. PubMed ID: 16713394 [TBL] [Abstract][Full Text] [Related]
2. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422 [TBL] [Abstract][Full Text] [Related]
3. [Trans-fatty acids--effects on coronary heart disease]. Karbowska J; Kochan Z Pol Merkur Lekarski; 2011 Jul; 31(181):56-9. PubMed ID: 21870712 [TBL] [Abstract][Full Text] [Related]
4. The scientific basis for TFA regulations-is it sufficient? Comments from the USA. Willett WC Atheroscler Suppl; 2006 May; 7(2):69-71. PubMed ID: 16716766 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of high-oleic vegetable oil substitutions for other fats and oils on cardiovascular disease risk factors: implications for novel high-oleic soybean oils. Huth PJ; Fulgoni VL; Larson BT Adv Nutr; 2015 Nov; 6(6):674-93. PubMed ID: 26567193 [TBL] [Abstract][Full Text] [Related]
7. Trans fatty acids, lipoproteins, and coronary risk. Zock PL; Katan MB Can J Physiol Pharmacol; 1997 Mar; 75(3):211-6. PubMed ID: 9164704 [TBL] [Abstract][Full Text] [Related]
8. Health effects of trans-fatty acids: experimental and observational evidence. Mozaffarian D; Aro A; Willett WC Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Chardigny JM; Malpuech-Brugère C; Dionisi F; Bauman DE; German B; Mensink RP; Combe N; Chaumont P; Barbano DM; Enjalbert F; Bezelgues JB; Cristiani I; Moulin J; Boirie Y; Golay PA; Giuffrida F; Sébédio JL; Destaillats F Contemp Clin Trials; 2006 Aug; 27(4):364-73. PubMed ID: 16632411 [TBL] [Abstract][Full Text] [Related]
10. Trans fatty acids: are its cardiovascular risks fully appreciated? Nestel P Clin Ther; 2014 Mar; 36(3):315-21. PubMed ID: 24636816 [TBL] [Abstract][Full Text] [Related]
12. Trans fatty acids and cardiovascular health: translation of the evidence base. Booker CS; Mann JI Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):448-56. PubMed ID: 18468872 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Hunter JE; Zhang J; Kris-Etherton PM Am J Clin Nutr; 2010 Jan; 91(1):46-63. PubMed ID: 19939984 [TBL] [Abstract][Full Text] [Related]
15. [Trans fatty acids: effects on lipoprotein metabolism and cardiovascular risk]. Attia-Skhiri N; Fournier N; Pourci ML; Paul JL Ann Biol Clin (Paris); 2009; 67(5):517-23. PubMed ID: 19789123 [TBL] [Abstract][Full Text] [Related]
16. Role of trans fatty acids in health and challenges to their reduction in Indian foods. Ghafoorunissa G Asia Pac J Clin Nutr; 2008; 17 Suppl 1():212-5. PubMed ID: 18296340 [TBL] [Abstract][Full Text] [Related]
17. Plasma Yang Q; Zhang Z; Loustalot F; Vesper H; Caudill SP; Ritchey M; Gillespie C; Merritt R; Hong Y; Bowman BA J Nutr; 2017 May; 147(5):896-907. PubMed ID: 28381527 [No Abstract] [Full Text] [Related]